Institutional Ownership
Alnylam Pharmaceuticals Inc
CUSIP 02043QAB3NOTE 1.000% 9/1ALNYQ1 2026
No short-interest data on record yet
FINRA publishes consolidated short interest twice a month. Coverage expands as the bi-monthly feed runs.
CUSIP 02043QAB3NOTE 1.000% 9/1ALNYQ1 2026
No short-interest data on record yet
FINRA publishes consolidated short interest twice a month. Coverage expands as the bi-monthly feed runs.